Shattuck Labs (STTK) Asset Writedowns and Impairment (2022 - 2025)
Shattuck Labs (STTK) posted quarterly Asset Writedowns and Impairment of $81000.0 for Q4 2025, up 8.0% year-over-year from $75000.0 in Q4 2024, and up 8.0% quarter-over-quarter from $75000.0 in Q4 2024.
Analysis
Shattuck Labs (STTK) Asset Writedowns and Impairment (2022 - 2025) Analysis & Trends
Shattuck Labs (STTK) has reported Asset Writedowns and Impairment for 4 consecutive years, with $81000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment rose 8.0% year-over-year to $81000.0; the TTM figure through Dec 2025 stood at $156000.0 (down 58.73% YoY), while the FY2025 annual figure was $81000.0, down 63.51% from the prior year.
- Asset Writedowns and Impairment grew to $81000.0 in Q4 2025 per STTK's latest filing, from $75000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $400000.0 in Q2 2022 and bottomed at $75000.0 in Q4 2024.
- Historically, Asset Writedowns and Impairment has averaged $209833.3 across 4 years, with a median of $151500.0 in 2023.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment slumped 49.0% — and 2025, when it rose 8.0%.
- Shattuck Labs' Asset Writedowns and Impairment stood at $400000.0 in 2022, then sank by 75.25% to $99000.0 in 2023, then decreased by 24.24% to $75000.0 in 2024, then advanced by 8.0% to $81000.0 in 2025.
- Business Quant data shows STTK's Asset Writedowns and Impairment at $81000.0 in Q4 2025, $75000.0 in Q4 2024, and $99000.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Shattuck Labs | 885.09 Mn | 885.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 81,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 400,000.00 |